Cytek Biosciences Statistics
NASDAQ: CTKBHealthcareMedical DevicesUSD
5.34-0.04 (-0.74%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cytek Biosciences by the numbers
Cytek Biosciences has a market capitalization of $694.1 million based on 129.98M shares outstanding. With trailing EPS of $-0.62, Cytek Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.2% above its 50-day average and 15.5% above its 200-day average.
Average daily trading volume is 1.03M shares, or about $5.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTKB valuation vs. peer median
| Metric | CTKB | Peer median | Difference |
|---|---|---|---|
| Market cap | $694.11M | $783.74M | -11% |
| Forward P/E | 76.3 | 10.2 | +647% |
| Avg. volume | 1.03M | 861.75K | +19% |
Peer median across 8 companies: AVR, VREX, AHCO, INMD, KIDS, QDEL, PACB, SSII.
Valuation
- Market cap
- $694.11M
- Forward P/E
- 76.29
- EPS (TTM)
- $-0.62
- Shares outstanding
- 129.98M
Price and trading
- Previous close
- 5.38
- Open
- 5.21
- Day range
- 5.11 – 5.34
- 52-week range
- 3.31 – 6.21
- 52-week change
- +40.90%
- Beta
- —
- Volume
- 1.78M
- Average volume
- 1.03M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 694.11M
- Forward Pe
- 76.29
- Eps
- -0.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.21
- Week52 Low
- 3.31
- Avg Volume
- 1.03M
- Shares Outstanding
- 129.98M
- Ma50
- 4.89
- Ma200
- 4.62
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -14.01%
- Pct From52w Low
- 61.33%